Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$18.4M
+36.5% from 2023
Prescriptions
2,487
$7,401.74 per claim
Patients
226
203 prescribers
Total spending, 2024
$18.4M
$81,451.89 per patient
Medicare prescription drug plans paid $18.4M for Xembify in 2024, for 2,487 prescriptions and refills to 226 patients (up 36.5% from 2023). The average cost per claim was $7,401.74.
California had the highest Medicare cost for Xembify in 2024: $2.4M for 292 claims, followed by Georgia ($1.6M).
Todd D Levine, neurology in Phoenix, AZ, had the highest Medicare cost for Xembify in 2024: 35 claims costing $830K.
Xembify is made by Grifols, S.a. (GRFS), listed in the Medicare spending data as Grifols Therape.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Todd D Levine Phoenix, AZ | Neurology | 35 | Under 11 | $830K |
| Samir P Macwan Rancho Mirage, CA | Neurology | 41 | Under 11 | $626K |
| William H Nesbit Tulsa, OK |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 101 | 1,298 | 112 | $11.2M |
| 2023 | 138 | 1,781 | 150 | $13.5M |
| 2024 | 203 | 2,487 | 226 | $18.4M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Family Practice |
| 33 |
| Under 11 |
| $502K |
| Irene Greenhouse Jamison, PA | Neurology | 18 | Under 11 | $478K |
| Lisa D Hobson-Webb Durham, NC | Neurology | 13 | Under 11 | $472K |
| Sami L Khella Philadelphia, PA | Neurology | 36 | Under 11 | $396K |
| Donald Negroski Sarasota, FL | Neurology | 12 | Under 11 | $355K |
| Jerrica Farias Tampa, FL | Nurse Practitioner | 13 | Under 11 | $333K |
| Michael A Taormina Statesboro, GA | Neurology | 36 | Under 11 | $317K |
| David E Burns Houston, TX | Rheumatology | 14 | Under 11 | $317K |
| Jemima Felicity L Albayda Baltimore, MD | Rheumatology | 11 | Under 11 | $311K |
| Vinod M Krishnan Crestview Hills, KY | Neurology | 26 | Under 11 | $311K |
| Khalid Malik Texarkana, TX | Neurology | 24 | Under 11 | $303K |
| Abigail M Stocker Louisville, KY | Gastroenterology | 26 | Under 11 | $291K |
| Dennis A Robinson Albany, GA | Allergy/ Immunology | 62 | Under 11 | $284K |
| Antoine Azar Baltimore, MD | Allergy/ Immunology | 13 | Under 11 | $268K |
| James A Ware Jr. Hamilton, NJ | Neurology | 11 | Under 11 | $241K |
| Todd M Hrabak Glendale, AZ | Allergy/ Immunology | 15 | Under 11 | $232K |
| David R Mayans Wichita, KS | Neurology | 42 | Under 11 | $208K |
| Rajani R Caesar Longview, TX | Neurology | 23 | Under 11 | $207K |
| Jason E Casselman Richmond, IN | Allergy/ Immunology | 37 | Under 11 | $201K |
| Myron Liebhaber Santa Barbara, CA | Allergy/ Immunology | 26 | Under 11 | $197K |
| John M Dengler Johnson City, TN | Neurology | 13 | Under 11 | $189K |
| Payam Soltanzadeh Los Angeles, CA | Neurology | 13 | Under 11 | $185K |
| Ofer Zimmerman Saint Louis, MO | Allergy/ Immunology | 24 | Under 11 | $180K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Grifols Therape GRFS | 2,487 | $18.4M |